Diffusion Microstructure Imaging to Analyze Perilesional T2 Signal Changes in Brain Metastases and Glioblastomas.

cerebral metastasis diffusion magnetic resonance imaging diffusion tensor imaging glioblastoma

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
23 Feb 2022
Historique:
received: 30 12 2021
revised: 21 02 2022
accepted: 22 02 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 11 3 2022
Statut: epublish

Résumé

Purpose: Glioblastomas (GBM) and brain metastases are often difficult to differentiate in conventional MRI. Diffusion microstructure imaging (DMI) is a novel MR technique that allows the approximation of the distribution of the intra-axonal compartment, the extra-axonal cellular, and the compartment of interstitial/free water within the white matter. We hypothesize that alterations in the T2 hyperintense areas surrounding contrast-enhancing tumor components may be used to differentiate GBM from metastases. Methods: DMI was performed in 19 patients with glioblastomas and 17 with metastatic lesions. DMI metrics were obtained from the T2 hyperintense areas surrounding contrast-enhancing tumor components. Resected brain tissue was assessed in six patients in each group for features of an edema pattern and tumor infiltration in the perilesional interstitium. Results: Within the perimetastatic T2 hyperintensities, we observed a significant increase in free water (p < 0.001) and a decrease in both the intra-axonal (p = 0.006) and extra-axonal compartments (p = 0.024) compared to GBM. Perilesional free water fraction was discriminative regarding the presence of GBM vs. metastasis with a ROC AUC of 0.824. Histologically, features of perilesional edema were present in all assessed metastases and absent or marginal in GBM. Conclusion: Perilesional T2 hyperintensities in brain metastases and GBM differ significantly in DMI-values. The increased free water fraction in brain metastases suits the histopathologically based hypothesis of perimetastatic vasogenic edema, whereas in glioblastomas there is additional tumor infiltration.

Identifiants

pubmed: 35267463
pii: cancers14051155
doi: 10.3390/cancers14051155
pmc: PMC8908999
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Arch Neurol. 2012 Apr;69(4):523-6
pubmed: 22158715
Neuroimage. 2018 Jul 1;174:518-538
pubmed: 29544816
Radiology. 2004 Jul;232(1):221-8
pubmed: 15220505
Neuroimage. 2016 Nov 15;142:394-406
pubmed: 27523449
Neuroimage. 2017 Feb 15;147:964-975
pubmed: 27746388
Acta Neuropathol. 1997 Feb;93(2):109-17
pubmed: 9039457
BMC Med Imaging. 2020 Nov 23;20(1):124
pubmed: 33228564
Curr Oncol Rep. 2012 Feb;14(1):48-54
pubmed: 22012633
J Neurosurg. 2016 Apr;124(4):977-88
pubmed: 26495941
PLoS One. 2017 Jan 19;12(1):e0169292
pubmed: 28103256
AJNR Am J Neuroradiol. 2014 Mar;35(3):439-44
pubmed: 24052506
AJNR Am J Neuroradiol. 2009 Jan;30(1):203-8
pubmed: 18842762
Front Oncol. 2019 Nov 22;9:1288
pubmed: 31824861
Mayo Clin Proc. 1987 Jun;62(6):450-9
pubmed: 3553757
Acta Radiol. 2018 May;59(5):599-605
pubmed: 28835111
Sci Rep. 2018 Mar 14;8(1):4561
pubmed: 29540809
Cereb Cortex. 2021 Sep 13;:
pubmed: 34515307
J Neurooncol. 2000 Oct-Nov;50(1-2):109-20
pubmed: 11245271
Neurosurg Clin N Am. 1994 Jan;5(1):19-33
pubmed: 8124091
J Neurosurg. 1995 Oct;83(4):682-9
pubmed: 7674019
Surg Neurol Int. 2013 May 02;4(Suppl 4):S245-55
pubmed: 23717796
Neurology. 2009 Apr 7;72(14):1217-22
pubmed: 19349600
PLoS One. 2014 Nov 07;9(11):e112550
pubmed: 25380185
Neuroimage. 2012 Jul 16;61(4):1000-16
pubmed: 22484410
Eur J Radiol. 2016 Dec;85(12):2182-2187
pubmed: 27842664
Magn Reson Med. 2016 Nov;76(5):1574-1581
pubmed: 26745823
World Neurosurg. 2015 Oct;84(4):1084-9
pubmed: 26008141
Sci Rep. 2021 Oct 1;11(1):19552
pubmed: 34599204
BMC Cancer. 2011 Apr 12;11:127
pubmed: 21481277
Acta Radiol. 2006 Apr;47(3):311-9
pubmed: 16613314
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Neuro Oncol. 2021 Oct 5;23(12 Suppl 2):iii1-iii105
pubmed: 34608945

Auteurs

Urs Würtemberger (U)

Department of Neuroradiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Martin Diebold (M)

Institute of Neuropathology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
IMM-PACT Clinician Scientist Program, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Daniel Erny (D)

Institute of Neuropathology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Berta-Ottenstein-Program for Advanced Clinician Scientists, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Jonas A Hosp (JA)

Department of Neurology and Neurophysiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Oliver Schnell (O)

Department of Neurosurgery, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Peter C Reinacher (PC)

Department of Stereotactic and Functional Neurosurgery, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Fraunhofer Institute for Laser Technology, 52074 Aachen, Germany.

Alexander Rau (A)

Department of Neuroradiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Department of Diagnostic and Interventional Radiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Elias Kellner (E)

Department of Medical Physics, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Marco Reisert (M)

Department of Stereotactic and Functional Neurosurgery, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Department of Medical Physics, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Horst Urbach (H)

Department of Neuroradiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Theo Demerath (T)

Department of Neuroradiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Classifications MeSH